Arthritis Today – April 2000

Issue 108Arthritis Today Issue 108 Cover

White blood cells and warning bells

In the second of a series of articles aimed at simplifying science, Professor Brian Henderson of University College, London, explains the role of white blood cells (leukocytes) in arthritis.

Devil's claw or green-lipped mussels? We're open-minded, says leading arthritis charity

The Arthritis Research Campaign is launching a major new initiative to fund research into complementary therapies after more than 60 years of concentrating on laboratory-based science.

New COX-2 drug – trial results

Clinical trials have shown that the COX-2 inhibitor celecoxib works as well as existing NSAIDs – and has fewer side effects on the stomach.

Enbrel drug shortage – but Remicade imminent

Thousands of rheumatoid arthritis patients in the UK will be unable to get hold of one of the two new biologic drugs at least until the end of the year – because the drug company manufacturing it has run out of supplies.

Focus on Glasgow: the Scottish dimension

Despite its social problems, Glasgow's eminence as a major centre for arthritis research and care has never been higher and a major new arc grant has further strengthened its position.

British glucosamine trial results still on hold

Results of a trial into the effectiveness of the dietary supplement glucosamine sulphate are expected to be published in a leading UK medical journal within the next few months.

Hands-on approach

For the first time, the arc has awarded a Postdoctoral Fellowship to a physiotherapist. Dr Mike Hurley explains the importance of his research into knee osteoarthritis.

New health web site goes on line

A new health website has been launched which aims to provide a comprehensive and interactive health portal to patients, carers and professionals.

Not simply aches and pains

Understanding polymyalgia rheumatica and giant cell arteritis. Dr Brian Hazelman and Dr Simon Burnet, from the Rheumatology Research Unit at Addenbrooke's Hospital, Cambridge, dispel some myths surrounding this common and treatable condition.